Form 4: Damon DeSantis Consolidates INBP Holdings
Statement of Changes in Beneficial Ownership
Director Damon DeSantis consolidated 11,201,964 shares of Integrated BioPharma, Inc. into CDDS 2.0, LLC.
Summary
- Damon DeSantis, a Director and 10% owner of Integrated BioPharma, Inc. (INBP), reported a consolidation of share ownership.
- A total of 8,966,547 shares were transferred from CD Financial, LLC to CDDS 2.0, LLC.
- An additional 2,235,417 shares were transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC.
- Following these transactions, the total beneficial ownership held by CDDS 2.0, LLC is 12,733,058 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a structural reorganization of existing holdings rather than an open-market purchase or sale.
Positives
- The transaction represents a consolidation of ownership under a single entity controlled by the reporting person, which may simplify governance and oversight.
Negatives
- None identified; this is a non-market transfer of ownership between affiliated entities.
Risks
- Concentration of voting power within a single entity (CDDS 2.0, LLC) controlled by the reporting person.
Future Outlook
No forward-looking guidance or operational outlook provided in this filing.
Industry Context
StockSavvy.ai notes that internal share transfers between affiliated entities are common in family-controlled or closely-held corporations for estate planning or structural simplification purposes and generally do not signal a change in market sentiment.
Comparison to Industry Standards
- The filing is consistent with standard SEC reporting requirements for insiders consolidating holdings.
Related Party Transactions
- Transfer of 8,966,547 shares from CD Financial, LLC to CDDS 2.0, LLC.
- Transfer of 2,235,417 shares from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC.
Stakeholder Impact
- Shareholders should note the increased concentration of voting power in CDDS 2.0, LLC.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 04/15/2026 | Date of the share transfer transactions. |
| 04/17/2026 | Date the Form 4 was signed and filed. |
Keywords
Integrated BioPharma, INBP, Form 4, Insider Trading, Beneficial Ownership, Damon DeSantis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.